Patients with multiple sclerosis found to have gut microbe changes

June 29, 2016 by Bob Yirka report
Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia

(Medical Xpress)—A team of researchers with Brigham and Women's Hospital at Harvard Medical School has discovered that people with multiple sclerosis appear to have differences in their gut biome than the rest of the population. In their paper published in the journal Nature Communications, the researchers describe testing they undertook of patients that had MS and of others in a control group, and the differences they found in levels of gut microbes between the two.

Multiple sclerosis (MS) is an incurable progressive disease that involves erosion of the myelin sheathing that covers nerve cells in the brain and spinal column. Patients who have it typically experience numbness in limbs, speech deterioration, problems with muscle control, trouble with vision and chronic fatigue. Prior research has suggested that it is an auto-immune disease –in this new effort, the researchers looked to the biome to determine if any changes might be present for those with the disease, because other auto-immune disease have been found to do so.

To find out, the researchers collected fecal samples from 63 people known to have MS, along with 43 samples from people without the disease. In studying the samples, the researchers found no measurable differences in overall biome diversity, but they did find elevated numbers of two types of bacteria—Methanobrevibacter and Akkermansia. To make sure the elevations were not due to medications given to MS patients, the team split the initial samples into two groups, those that had been treated with drugs, and those that had not. Both groups were found to have elevated levels of the bacteria—they also noted that both groups also had a slight decline in Butyricimonas.

The researchers then conducted a profile of related genes in T-cells looking for connections to the changes in the gut biome and found that there was a relationship between them and activation of interferon and other inflammatory pathways—the levels of which were consistent with the degree of bacterial gut level increases.

Finally, the team analyzed breath samples that had also been taken from all the patients and controls and found slightly elevated levels of methane in MS patients, which made sense, because the types of bacteria with elevated levels found in their biomes, were the type that are known to produce methane in the gut.

Intestinal microbiome composition from healthy controls (HC), untreated MS patients (MS-U), and MS patients on disease modifying therapy (MS-Tr) measured on two different high-throughput DNA sequencing platforms, Roche 454 and Illumina MiSeq. Credit: Howard Weiner, Brigham and Women's Hospital

The results of the study suggest that biome testing could become a new means of testing for MS, charting its progression, or perhaps even as part of the development of drugs meant to treat it.

Explore further: Children with and without multiple sclerosis have differences in gut bacteria

More information: Sushrut Jangi et al. Alterations of the human gut microbiome in multiple sclerosis, Nature Communications (2016). DOI: 10.1038/ncomms12015

Abstract
The gut microbiome plays an important role in immune function and has been implicated in several autoimmune disorders. Here we use 16S rRNA sequencing to investigate the gut microbiome in subjects with multiple sclerosis (MS, n=60) and healthy controls (n=43). Microbiome alterations in MS include increases in Methanobrevibacter and Akkermansia and decreases in Butyricimonas, and correlate with variations in the expression of genes involved in dendritic cell maturation, interferon signalling and NF-kB signalling pathways in circulating T cells and monocytes. Patients on disease-modifying treatment show increased abundances of Prevotella and Sutterella, and decreased Sarcina, compared with untreated patients. MS patients of a second cohort show elevated breath methane compared with controls, consistent with our observation of increased gut Methanobrevibacter in MS in the first cohort. Further study is required to assess whether the observed alterations in the gut microbiome play a role in, or are a consequence of, MS pathogenesis.

Press release

Related Stories

Children with and without multiple sclerosis have differences in gut bacteria

May 16, 2016
In a recent study, children with multiple sclerosis had differences in the abundance of specific gut bacteria than children without the disease. Certain types of bacteria were either more or less abundant in children with ...

Researchers find link between gut bacteria and MS

June 27, 2016
If asked to list problems that bad gut bacteria can cause, most would likely name digestive issues: constipation, excessive gas, or diarrhea.

Researchers identify genes associated with specific metabolic pathways

October 2, 2015
(Medical Xpress)—An international team of researchers working at the Washington University School of Medicine in Missouri has identified several genes associated with specific metabolic pathways in a mammal biome, including ...

Exploring the gut-brain connection for insights into multiple sclerosis

May 9, 2016
New research by investigators at Brigham and Women's Hospital (BWH) suggests that bacteria living in the gut may remotely influence the activity of cells in the brain that are involved in controlling inflammation and neurodegeneration. ...

Indicator of chronic fatigue syndrome found in gut bacteria

June 27, 2016
Physicians have been mystified by chronic fatigue syndrome, a condition where normal exertion leads to debilitating fatigue that isn't alleviated by rest. There are no known triggers, and diagnosis requires lengthy tests ...

Gut microbiome of mother found to impact immunity of mice pups

March 18, 2016
(Medical Xpress)—A team of researchers from Switzerland and Germany has found that the gut microbiome of a pregnant mouse can have an impact on the development of the immune system in the pups she delivers. In their paper ...

Recommended for you

Scientists find key to regenerating blood vessels

November 23, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels. The ...

Surprising roles for muscle in tissue regeneration, study finds

November 22, 2017
A team of researchers at Whitehead has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration. In a paper published in the November 22 issue of Nature, they ...

Study reveals new mechanisms of cell death in neurodegenerative disorders

November 22, 2017
Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

Cinnamon turns up the heat on fat cells

November 21, 2017
New research from the University of Michigan Life Sciences Institute has determined how a common holiday spice—cinnamon—might be enlisted in the fight against obesity.

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.